ADC	antibody–drug conjugate
AID	activation-induced cytidine deaminase
AMP	Association for Molecular Pathology
BCT	blood collection tube
bp	base pairs
BsAb	bispecific antibody
CAP	College of American Pathologists
CAPP-Seq	Cancer Personalized Profiling by deep Sequencing
CAR-T	chimeric antigen receptor T-cell
cfDNA	cell-free DNA
cfMeDIP-seq	cell-free methylated DNA immunoprecipitation and sequencing
CHIP	clonal hematopoiesis of indeterminate potential
CI	confidence interval
CRS	cytokine release syndrome
cSMART	circulating single-molecule amplification and re-sequencing technology
ctDNA	circulating tumor DNA
ddPCR	droplet digital polymerase chain reaction
DLBCL	diffuse large B-cell lymphoma
EFS	event-free survival
EMR	early molecular response
FDA	United States Food and Drug Administration
hGE/mL	haploid genome equivalents per milliliter
ICANS	immune effector cell-associated neurotoxicity syndrome
iDES	integrated digital error suppression
Ig-HTS	immunoglobulin high-throughput sequencing
IPI	International Prognostic Index
LBCL	large B-cell lymphoma
LDH	lactate dehydrogenase
LOD	limit of detection
MMR	major molecular response
MRD	minimal/measurable residual disease
NCCN	National Comprehensive Cancer Network
NGS	next-generation sequencing
NPV	negative predictive value
OS	overall survival
PCR	polymerase chain reaction
PET/CT	positron emission tomography/computed tomography
PFS	progression-free survival
PPV	positive predictive value
R/R	relapsed/refractory
R-IPI	Revised International Prognostic Index
SNV	single-nucleotide variant
TMTV	total metabolic tumor volume
VAF	variant allele frequency
V(D)J	variable, diversity, and joining gene segment